Physician profile
David E Wood
NPI 1821087479
$2,293.20
in general payments reported to CMS, 2019-2025
15 companies · $404 in 2025
The $404 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $891 · 2021: $83.13 · 2022: $82.42 · 2023: $237 · 2024: $458 · 2025: $404.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,098.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,098.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,180.47 | 2020-2025 | Impella |
| Medtronic, INC. | $367.04 | 2021-2025 | Symplicity G3, Acist Rxi System, Ffrangio |
| Boston Scientific Corporation | $167.31 | 2021-2025 | General - Catheter, General - Therapies, Watchman Flx |
| Edwards Lifesciences Corporation | $158.69 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $112.02 | 2022-2025 | Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $60.12 | 2019-2024 | Lifevest |
| Janssen Pharmaceuticals, INC | $47.96 | 2019 | |
| Baxter Healthcare | $38.24 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Astrazeneca Pharmaceuticals Lp | $33.62 | 2019-2020 | |
| Shockwave Medical, INC | $28.24 | 2025 | |
| Amgen INC. | $27.00 | 2019 | |
| Novo Nordisk INC | $21.37 | 2024 | Ozempic |
| Ge Healthcare | $19.90 | 2020 | |
| Lantheus Medical Imaging, INC. | $18.91 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Wood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.